B. Riley Wealth Advisors Inc. Sells 1,074 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

B. Riley Wealth Advisors Inc. lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.5% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,330 shares of the company’s stock after selling 1,074 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in GE HealthCare Technologies were worth $489,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Fortitude Family Office LLC bought a new stake in GE HealthCare Technologies in the fourth quarter worth about $29,000. Turtle Creek Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $30,000. Sachetta LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $31,000. Central Bank & Trust Co. bought a new position in GE HealthCare Technologies during the fourth quarter valued at $33,000. Finally, Valued Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies in the fourth quarter worth $33,000. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Mizuho lowered their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Argus raised their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Finally, Citigroup boosted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.09.

Insider Buying and Selling at GE HealthCare Technologies

In related news, insider Frank R. Jimenez acquired 1,315 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was bought at an average cost of $76.52 per share, with a total value of $100,623.80. Following the acquisition, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Jan Makela sold 20,227 shares of GE HealthCare Technologies stock in a transaction on Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,167,296.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Frank R. Jimenez purchased 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The disclosure for this purchase can be found here. Insiders sold a total of 90,482 shares of company stock worth $7,369,137 over the last three months. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Stock Down 0.3 %

GEHC opened at $79.17 on Monday. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The firm has a market capitalization of $36.14 billion, a P/E ratio of 23.15, a price-to-earnings-growth ratio of 2.86 and a beta of 1.22. The company has a fifty day moving average price of $80.53 and a 200-day moving average price of $81.58.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.85 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.